Hepatitis B Virus Reactivation in Patients with Previously Resolved Hepatitis B Treated with Rituximab-Containing Chemotherapy for B-Cell Lymphoma


Creative Commons License

ÇAKMAK E.

ERCIYES MEDICAL JOURNAL, cilt.40, ss.28-34, 2018 (ESCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 40 Konu: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/etd.2018.18008
  • Dergi Adı: ERCIYES MEDICAL JOURNAL
  • Sayfa Sayıları: ss.28-34

Özet

Objective: This study aimed to determine the frequency of HBV reactivation and the potential predictive factors in resolved hepatitis B virus (HBV) patients [hepatitis B surface antigen (HBsAg)-negative and antibody to hepatitis B core antigen (antiHBc)-positive patients] who received rituximab-containing chemotherapy for B-cell lymphoma.